RS

Rahul Sahay

Active Director Director DIN 07432489
DIN 07432489 First appointment Feb 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Rahul Sahay

Data last updated:

Rahul Sahay is a Director at Sanchi Pharmaceuticals Private Limited (since 2016). The company operates in Trading. Sanchi Pharmaceuticals Private Limited reported revenue of ₹4.4 Lakh (FY 2024).

DIN 07432489
Primary Designation Director
Industry Trading
First Appointment 23 Feb 2016
Oldest Company Age 18 yrs
Largest company Sanchi Pharmaceuticals Private Limited · ₹4.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Feb 20162008₹4.4 Lakh (FY 2024)Active

Board colleagues of Rahul Sahay

NameDINCompanyDesignation
Ramkayash Singh07432504Sanchi Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sanchi Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rahul Sahay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Sahay

Rahul Sahay currently holds 1 directorship: Sanchi Pharmaceuticals Private Limited (Director, since 23 Feb 2016, revenue ₹4.4 Lakh (FY 2024)).

Rahul Sahay was first appointed on 23 Feb 2016 as Director at Sanchi Pharmaceuticals Private Limited.

The current boards of Rahul Sahay's companies include Ramkayash Singh (Sanchi Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available